Callisto Pharmaceuticals (KAL) Receives Non-Compliance Notification From AMEX
Callisto Pharmaceuticals, Inc. (Amex: KAL) received notice from the American Stock Exchange (AMEX) indicating that the Company is below certain of the Exchange\'s continued listing standards, as set forth in Section 1003 (a) (ii) of the AMEX Company Guide, in that the Company, as of March 31, 2007, had Stockholders\' Equity of less than $4,000,000 and also had sustained losses from continuing operations and/or net losses in three of its four most recent fiscal years.
In accordance with AMEX rules, by July 18, 2007 the Company will submit a plan for review by the Exchange to demonstrate the Company\'s ability to regain compliance by April 3, 2008.
In accordance with AMEX rules, by July 18, 2007 the Company will submit a plan for review by the Exchange to demonstrate the Company\'s ability to regain compliance by April 3, 2008.
You May Also Be Interested In
- Auxilium (AUXL) Files Suit Against Watson (WPI) Over Testim 1% Gel
- Mylan (MYL) Launches Generic Bonviva Tabs (RHHBY) in Italy & the U.K.
- Sony (SNE) Said to Pay for 3-D Glasses for 'Men In Black 3' -Bloomberg (RLD)
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
